 |
 |

Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis
Bas Jasperse, MD;
Arjan Minneboo, MD;
Vincent de Groot, MD;
Nynke F. Kalkers, MD, PhD;
Paul E. van Helden, MSc;
Bernard M. J. Uitdehaag, MD, PhD;
Frederik Barkhof, MD, PhD;
Chris H. Polman, MD, PhD
Arch Neurol. 2007;64(2):190-194.
Objective To identify determinants visible on magnetic resonance imaging of the brain that explain the subsequent rate of cerebral atrophy in patients with recently diagnosed multiple sclerosis.
Design Magnetic resonance imaging of the brain was performed at baseline and after 2 years. T2 hyperintense lesion load, black hole lesion load, presence of contrast-enhancing lesions, and normalized brain volume were derived from the baseline magnetic resonance imaging and considered as possible explanatory variables for the subsequent annualized percentage of brain volume change (PBVC/y) using forward stepwise multiple linear regression analysis.
Setting MS center Amsterdam, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
Patients Eighty-nine patients recently diagnosed as having multiple sclerosis were included at the time of diagnosis from our outpatient clinic.
Main Outcome Measure Annualized percentage of brain volume change.
Results The mean (SD) annualized rate of cerebral atrophy was –0.9 (0.8) PBVC/y. Baseline normalized brain volume (standardized coefficient, 0.426; P = .001) and baseline T2 lesion load (standardized coefficient, –0.244; P = .02) were identified as explanatory variables for subsequent PBVC/y and yielded a regression model that explained 31.2% of the variance in PBVC/y.
Conclusions In patients with recently diagnosed multiple sclerosis, the extent of accumulated brain tissue loss and overall lesion load partly explain the subsequent rate of cerebral atrophy.
Author Affiliations: Departments of Neurology (Drs Jasperse, Kalkers, Uitdehaag, and Polman), Radiology (Drs Minneboo and Barkhof and Mr van Helden), and Rehabilitation Medicine (Dr de Groot), VU University Medical Center, Amsterdam, the Netherlands.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
What Causes Multiple Sclerosis to Worsen?
J. Theodore Phillips
Arch Neurol. 2007;64(2):167-168.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients
Holst et al.
Mult Scler 2009;15:701-707.
ABSTRACT
Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
Korteweg et al.
Mult Scler 2009;15:465-471.
ABSTRACT
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
Minneboo et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:917-923.
ABSTRACT
| FULL TEXT
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis
Rasmussen et al.
Brain 2007;130:2816-2829.
ABSTRACT
| FULL TEXT
What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT
|